As of 2:50pm ET
| +0.025 / +0.09%|
The 2 analysts offering 12-month price forecasts for PharMerica Corp have a median target of 29.13, with a high estimate of 29.25 and a low estimate of 29.00. The median estimate represents a -0.17% decrease from the last price of 29.18.
The current consensus among 4 polled investment analysts is to Hold stock in PharMerica Corp. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.